Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity

Código QR

Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity

Guardado en:

Detalles Bibliográficos
Autores principales:	Shahram Salek-Ardakani, Wenjing Yang, Sheng Ding, Shih-Hsun Chen, Pawel K Dominik, Jessica Stanfield, Nadia Kurd, Ryan Llewellyn, Jonathan Heyen, Carole Wang, Zea Melton, Thomas Van Blarcom, Kevin C Lindquist, Javier Chaparro-Riggers
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/3920fe53e43c44dd89bb0d4a1c33ff53
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Generation of T-cell-redirecting bispecific antibodies with differentiated profiles of cytokine release and biodistribution by CD3 affinity tuning
por: Lauric Haber, et al.
Publicado: (2021)

Programmable half-life and anti-tumour effects of bispecific T-cell engager-albumin fusions with tuned FcRn affinity
por: Ole A. Mandrup, et al.
Publicado: (2021)

Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells
por: Demet Candas-Green, et al.
Publicado: (2020)

Direct control of CAR T cells through small molecule-regulated antibodies
por: Spencer Park, et al.
Publicado: (2021)

Structure of the 4-1BB/4-1BBL complex and distinct binding and functional properties of utomilumab and urelumab
por: S. Michael Chin, et al.
Publicado: (2018)

A human CD137×PD-L1 bispecific antibody promotes anti-tumor immunity via context-dependent T cell costimulation and checkpoint blockade
por: Cecile Geuijen, et al.
Publicado: (2021)

Acta No. 47
por: Banco Central de Chile
Publicado: (2019)

Development of selective bispecific Wnt mimetics for bone loss and repair
por: Tristan W. Fowler, et al.
Publicado: (2021)

Bispecific T-Cell Engagers Targeting Membrane-Bound IgE
por: Aleksandra Rodak, et al.
Publicado: (2021)

Transfer of Cellular Content from the Allogeneic Cell-Based Cancer Vaccine DCP-001 to Host Dendritic Cells Hinges on Phosphatidylserine and Is Enhanced by CD47 Blockade
por: Haoxiao Zuo, et al.
Publicado: (2021)

EZH2 Inhibition Compromises α4-1BB-Mediated Antitumor Efficacy by Reducing the Survival and Effector Programming of CD8+ T Cells
por: Christopher J. Stairiker, et al.
Publicado: (2021)

CEPAL Review no.47
Publicado: (2015)

Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19
por: Martin A. Redhead, et al.
Publicado: (2021)

Computational stabilization of T cell receptors allows pairing with antibodies to form bispecifics
por: Karen Froning, et al.
Publicado: (2020)

A new approach to produce IgG4-like bispecific antibodies
por: Caizhi Zhao, et al.
Publicado: (2021)

T Cell Bispecific Antibodies: An Antibody-Based Delivery System for Inducing Antitumor Immunity
por: Daisuke Kamakura, et al.
Publicado: (2021)

Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells
por: Barbara Savoldo, et al.
Publicado: (2021)

Unconquered by the Blockade
por: E. M. Proshina
Publicado: (2018)

Editorial do número 47
por: Hervé Théry, et al.
Publicado: (2020)

ECLAC Notes Nº 47
Publicado: (2014)

Resolución 47(V): Compensaciones multilaterales de pagos = Resolution 47(V): Multilateral settlements of payments = Résolution 47(V): Compensations multilatérales de paiements
Publicado: (2014)

FoldAffinity: binding affinities from nDSF experiments
por: Stephan Niebling, et al.
Publicado: (2021)

In vivo pharmacokinetic enhancement of monomeric Fc and monovalent bispecific designs through structural guidance
por: Lu Shan, et al.
Publicado: (2021)

Publisher Correction: Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19
por: Martin A. Redhead, et al.
Publicado: (2021)

Efficient Generation of Bispecific Murine Antibodies for Pre-Clinical Investigations in Syngeneic Rodent Models
por: Aran F. Labrijn, et al.
Publicado: (2017)

A semi high-throughput method for screening small bispecific antibodies with high cytotoxicity
por: Aruto Sugiyama, et al.
Publicado: (2017)

Novel potent anti-STEAP1 bispecific antibody to redirect T cells for cancer immunotherapy
por: Hong-fen Guo, et al.
Publicado: (2021)

Editorial: Volume 47 Issue 2
por: Sawsen Lakhal, et al.
Publicado: (2021)

Identification of microsatellites linked to Lr47
por: Vanzetti,Leonardo Sebastián, et al.
Publicado: (2006)

International Rivers and Lakes Nº 47
por: Jouravlev, Andrei
Publicado: (2014)

Revista de la CEPAL no.47
Publicado: (2015)

TO THE QUESTION OF MAXIMIZING THE ENTERPRISES EFFICIENCY
por: V. Vasyaycheva
Publicado: (2016)

Maximizing the impacts of academic research
por: Samantha Jane Ahern
Publicado: (2021)

The electron affinity of astatine
por: David Leimbach, et al.
Publicado: (2020)

The structure of affine buildings
por: Weiss, Richard M. (Richard Mark), 1946-
Publicado: (2009)

Efficient and Highly Specific Gene Transfer Using Mutated Lentiviral Vectors Redirected with Bispecific Antibodies
por: Christina L. Parker, et al.
Publicado: (2020)

A novel bispecific antibody platform to direct complement activity for efficient lysis of target cells
por: Jonathan W. Cruz, et al.
Publicado: (2019)

A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer
por: Paola A. Betancur, et al.
Publicado: (2017)

Inhibition of glucose metabolism selectively targets autoreactive follicular helper T cells
por: Seung-Chul Choi, et al.
Publicado: (2018)

SYNTHESIS OF CONFORMATIONALLY RESTRICTED N-{4-[4-(4,7-DIMETHOXY-BENZO[b]THIOPHENE-2-CARBONYL)-1-PIPERAZINYL]-PHENYL}-ARYLCARBOXAMIDES POTENTIAL LIGANDS WITH 5-HT1A BINDING AFFINITY
por: PESSOA-MAHANA,HERNÁN, et al.
Publicado: (2009)